Rezultati - Sergio Iadevaia
- Showing 1 - 4 results of 4
-
1
-
2
MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors od Jonathan B. Fitzgerald, Bryan W. Johnson, Jason Baum, Sharlene Adams, Sergio Iadevaia, Jian Tang, Victoria Rimkunas, Lihui Xu, Neeraj Kohli, Rachel Rennard, Maja Razlog, Yang Jiao, Brian D. Harms, Kenneth J. Olivier, Birgit Schoeberl, Ulrik B. Nielsen, Alexey A. Lugovskoy
Izdano 2013Artigo -
3
Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling od Yiling Lu, Mathias Müller, David M. Smith, Bhaskar Dutta, Kakajan Komurov, Sergio Iadevaia, Derek Ruths, Julia Tseng, Shoujia Yu, Qinghua Yu, Luay Nakhleh, Gábor Balázsi, J. Donnelly, Mark E. Schurdak, Susan E. Morgan-Lappe, Stephen W. Fesik, Prahlad T. Ram, G B Mills
Izdano 2011Artigo -
4
Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic Cancer od Adam J. Camblin, Emily A. Pace, Sharlene Adams, Michael D. Curley, Victoria Rimkunas, Lin Nie, Gege Tan, Troy Bloom, Sergio Iadevaia, Jason Baum, Charlene Minx, Akos Czibere, Chrystal U. Louis, Daryl C. Drummond, Ulrik B. Nielsen, Birgit Schoeberl, J. Marc Pipas, Robert M. Straubinger, Vasileios Askoxylakis, Alexey A. Lugovskoy
Izdano 2018Artigo
Iskalna orodja:
Sorodne teme
Biochemistry
Signal transduction
Biology
Cancer
Cancer research
Cell biology
ERBB3
Epidermal growth factor receptor
Gene
Internal medicine
Medicine
PI3K/AKT/mTOR pathway
Pharmacology
Phosphorylation
Protein kinase B
Bioinformatics
Cancer cell
Chemistry
Computational biology
Drug discovery
GSK-3
Gemcitabine
Genetics
Kinase
Kinome
MAPK/ERK pathway
Nab-paclitaxel
Oncology
Paclitaxel
Pancreatic cancer